{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:50Z","timestamp":1787017070582,"version":"build-2736575974"},"reference-count":46,"publisher":"BMJ","funder":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"European Union\u2014Next Generation EU","award":["PNRR-MAD-2022-12376035"],"award-info":[{"award-number":["PNRR-MAD-2022-12376035"]}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["20059CB"],"award-info":[{"award-number":["20059CB"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006401","name":"Charcot Foundation","doi-asserted-by":"crossref","award":["D.7090"],"award-info":[{"award-number":["D.7090"]}],"id":[{"id":"10.13039\/501100006401","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALS Association\/ALS","award":["20059CB"],"award-info":[{"award-number":["20059CB"]}]},{"name":"ALS Association\/ALS","award":["23-PPG-674-2"],"award-info":[{"award-number":["23-PPG-674-2"]}]},{"name":"ALS Association\/ALS","award":["24-SGP-691"],"award-info":[{"award-number":["24-SGP-691"]}]},{"DOI":"10.13039\/100013301","name":"Parkinson\u2019s Foundation","doi-asserted-by":"publisher","award":["PF-PRF-934916"],"award-info":[{"award-number":["PF-PRF-934916"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DZNE Innovation-to-Application","award":["I2A_call7_Oeckl; I2A_call9_Oeckl"],"award-info":[{"award-number":["I2A_call7_Oeckl; I2A_call9_Oeckl"]}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Marie Sk\u0142odowska-Curie","award":["860197"],"award-info":[{"award-number":["860197"]}]},{"name":"Department of Health Generalitat de Catalunya PERIS","award":["SLT006\/17\/125"],"award-info":[{"award-number":["SLT006\/17\/125"]}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["DTS-22\/00111"],"award-info":[{"award-number":["DTS-22\/00111"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["INT19\/00016"],"award-info":[{"award-number":["INT19\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["INT23\/00048"],"award-info":[{"award-number":["INT23\/00048"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["PI18\/00327"],"award-info":[{"award-number":["PI18\/00327"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["PI18\/00435"],"award-info":[{"award-number":["PI18\/00435"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["PI21\/00327"],"award-info":[{"award-number":["PI21\/00327"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["PI22\/00611"],"award-info":[{"award-number":["PI22\/00611"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Faculty of Martin-Luther-University Halle-Wittenberg","award":["CS22\/06; JCSP24\/02"],"award-info":[{"award-number":["CS22\/06; JCSP24\/02"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,6,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Beta-synuclein is an emerging blood biomarker for detecting synaptic damage in Alzheimer\u2019s disease (AD) but its role in early AD as well as in other dementias is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured with immunoprecipitation mass-spectrometry serum beta-synuclein levels in an exploratory cohort of 80 patients recruited at the University of Perugia (Perugia, Italy) (n=56\u2009AD; n=24 controls) and in a validation cohort of 269 patients recruited at the University of Barcelona (Barcelona, Spain) (n=108\u2009AD; n=53 frontotemporal lobar degeneration (FTLD); n=73 dementia with Lewy bodies and mild cognitive impairment (MCI) with Lewy bodies, together Lewy body disease (LBD); n=27 controls). We tested associations with diagnostic groups, cognitive decline and other cerebrospinal fluid (CSF) and blood markers (phosphorylated tau protein in position 181 (pTau181), neurofilament light chain protein (NfL), glial fibrillar acidic protein (GFAP)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum beta-synuclein level was progressively increased in the AD continuum across the preclinical, MCI and dementia stages compared with controls and was correlated with serum pTau181 (r=0.710), NfL (r=0.494) and GFAP concentrations (r=0.621, p&lt;0.001 for all). The biomarker showed high accuracy for the discrimination of AD vs controls (area under the curve (AUC): 0.87) and AD-MCI vs non-AD MCI (AUC: 0.96). High serum beta-synuclein level was correlated with lower Mini-Mental State Examination (MMSE) points at baseline (r=\u22120.461, p&lt;0.001) and associated with MMSE change at follow-up after accounting for age, sex and the time from baseline to last follow-up visit (p=0.006). Serum beta-synuclein level was similar between FTLD and controls, whereas, in LBD, it was higher with AD copathology as evidenced by CSF analysis (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High serum beta-synuclein level is a promising biomarker for AD-related synaptic damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336189","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:20:33Z","timestamp":1750944033000},"page":"jnnp-2025-336189","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Serum level changes of the synaptic marker beta-synuclein in Alzheimer\u2019s disease continuum and other dementias"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-3620","authenticated-orcid":false,"given":"Lorenzo","family":"Barba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-3245","authenticated-orcid":false,"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"Wojdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-638X","authenticated-orcid":false,"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-8506","authenticated-orcid":false,"given":"Samir","family":"Abu-Rumeileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-5478","authenticated-orcid":false,"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-3967","authenticated-orcid":false,"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Belbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4273-4267","authenticated-orcid":false,"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-7023","authenticated-orcid":false,"given":"Patrick","family":"Oeckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2025062610201788000_jnnp-2025-336189v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2212948"},{"key":"2025062610201788000_jnnp-2025-336189v1.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324306"},{"key":"2025062610201788000_jnnp-2025-336189v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329124"},{"key":"2025062610201788000_jnnp-2025-336189v1.4","first-page":"e50","article-title":"CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease","volume":"101","author":"Barba","year":"2023","journal-title":"Neurology (ECronicon)"},{"key":"2025062610201788000_jnnp-2025-336189v1.5","doi-asserted-by":"crossref","DOI":"10.1002\/dad2.12179","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease","volume":"13","author":"Nilsson","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"2025062610201788000_jnnp-2025-336189v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51402"},{"key":"2025062610201788000_jnnp-2025-336189v1.7","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.059915"},{"key":"2025062610201788000_jnnp-2025-336189v1.8","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JPROTEOME.9B00824"},{"key":"2025062610201788000_jnnp-2025-336189v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12790"},{"key":"2025062610201788000_jnnp-2025-336189v1.10","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13103"},{"key":"2025062610201788000_jnnp-2025-336189v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00955-x"},{"key":"2025062610201788000_jnnp-2025-336189v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00616-3"},{"key":"2025062610201788000_jnnp-2025-336189v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2025062610201788000_jnnp-2025-336189v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2025062610201788000_jnnp-2025-336189v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"2025062610201788000_jnnp-2025-336189v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2025062610201788000_jnnp-2025-336189v1.17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.2338"},{"key":"2025062610201788000_jnnp-2025-336189v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2025062610201788000_jnnp-2025-336189v1.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"2025062610201788000_jnnp-2025-336189v1.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009323"},{"key":"2025062610201788000_jnnp-2025-336189v1.21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1212\/WNL.0000000000004919","article-title":"Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"90","author":"McKeith","year":"2018","journal-title":"Neurology"},{"key":"2025062610201788000_jnnp-2025-336189v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"2025062610201788000_jnnp-2025-336189v1.23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c47cc2"},{"key":"2025062610201788000_jnnp-2025-336189v1.24","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.647783","article-title":"Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer\u2019s Disease and Other Neurological Disorders","volume":"15","author":"Bellomo","year":"2021","journal-title":"Front Neurosci"},{"key":"2025062610201788000_jnnp-2025-336189v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.50873"},{"key":"2025062610201788000_jnnp-2025-336189v1.26","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01021-8","article-title":"Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer\u2019s disease","volume":"14","author":"Nilsson","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"2025062610201788000_jnnp-2025-336189v1.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-024-01440-9","article-title":"Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer\u2019s disease","volume":"16","author":"Wang","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"2025062610201788000_jnnp-2025-336189v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26446"},{"key":"2025062610201788000_jnnp-2025-336189v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13687"},{"key":"2025062610201788000_jnnp-2025-336189v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26462"},{"key":"2025062610201788000_jnnp-2025-336189v1.31","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330709"},{"key":"2025062610201788000_jnnp-2025-336189v1.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06916-4"},{"key":"2025062610201788000_jnnp-2025-336189v1.33","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230900"},{"key":"2025062610201788000_jnnp-2025-336189v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00214-3"},{"key":"2025062610201788000_jnnp-2025-336189v1.35","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0687-5","article-title":"Detection of Alzheimer\u2019s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)","volume":"7","author":"Gibbons","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"2025062610201788000_jnnp-2025-336189v1.36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae203"},{"key":"2025062610201788000_jnnp-2025-336189v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy146"},{"key":"2025062610201788000_jnnp-2025-336189v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad059"},{"key":"2025062610201788000_jnnp-2025-336189v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00520-w"},{"key":"2025062610201788000_jnnp-2025-336189v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00405-2"},{"key":"2025062610201788000_jnnp-2025-336189v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00404-0"},{"key":"2025062610201788000_jnnp-2025-336189v1.42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200878"},{"key":"2025062610201788000_jnnp-2025-336189v1.43","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13658"},{"key":"2025062610201788000_jnnp-2025-336189v1.44","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14151"},{"key":"2025062610201788000_jnnp-2025-336189v1.45","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"2025062610201788000_jnnp-2025-336189v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac333"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:20:36Z","timestamp":1750944036000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":46,"alternative-id":["10.1136\/jnnp-2025-336189"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336189","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}